Influence of GST Gene Polymorphisms on the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation

This publication has 40 references indexed in Scilit:

• Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring
  Blood, 2010
• Influence of GST gene polymorphisms on busulfan pharmacokinetics in children
  Bone Marrow Transplantation, 2009
• Glutathione S‐Transferase A1 Genetic Variants Reduce Busulfan Clearance in Children Undergoing Hematopoietic Cell Transplantation
  The Journal of Clinical Pharmacology, 2008
• Variability in the pharmacokinetics of intravenous busulphan given as a single daily dose to paediatric blood or marrow transplant recipients
  British Journal of Clinical Pharmacology, 2008
• Glutathione S‐transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug‐induced liver injury†
  Hepatology, 2008
• GSTM1, GSTT1 and GSTP1 Polymorphisms in the Korean Population
  Journal of Korean Medical Science, 2005
• Genetic analysis of glutathione S-transferase A1 and T1 polymorphisms in a Japanese population
  Clinical Chemistry and Laboratory Medicine (CCLM), 2004
• Immunohistochemical localization of human liver glutathione S-transferase (GST) isozymes with special reference to polymorphic GST1
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1989
• Allogeneic Bone Marrow Transplantation after Hyperfractionated Total-Body Irradiation and Cyclophosphamide in Children with Acute Leukemia
  New England Journal of Medicine, 1987
• Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide
  New England Journal of Medicine, 1983